Crofab Injection, Powder, Lyophilized, For Solution
Product Images NDC 50633-110

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Crofab (NDC 50633-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Btg International Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Crofab 01)

A line chart depicting platelet counts (10^3/mm^3) over time at baseline and nominal hours after initial control for six patients. The x-axis shows time points from baseline to 36 hours, and the y-axis shows platelet counts ranging from 0 to 350. Different line styles and markers represent individual patients and their treatment schedules, including some marked as PRN and Scheduled.*

FDA Label Image

Figure2 (Crofab 02)

Two line graphs showing platelet counts (10³/mm³) versus nominal days after discharge. The top graph represents data for the scheduled treatment group with platelet counts ranging from -300 to about 200 over 26 days. The bottom graph shows platelet counts for the PRN treatment group with multiple individual lines tracking counts from -300 to 300 over 26 days.*

FDA Label Image

Vial-label (Crofab 03)

Label for CroFab (Crotalidae Polyvalent Immune Fab, Ovine) injection powder, lyophilized for intravenous use. Instructions state to use immediately after reconstitution and store at 2° to 8°C (36° to 46°F), do not freeze. The label includes dosage and reconstitution details, a list of snake venoms neutralized, manufacturer (BTG International Inc., West Conshohocken, PA), NDC 50633-110-11, SKU 9011012, and barcodes.*

FDA Label Image

Carton-label (Crofab 04)

Packaging label for CroFab, Crotalidae Polyvalent Immune Fab (Ovine) injection. The label states the product contains two vials in lyophilized powder form for intravenous use, distributed by BTG International Inc. It includes storage instructions, reconstitution directions, and a barcode with NDC 50633-110-12.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.